ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Alkermes plc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$42.97+1.75 (+4.25%)
Close on Oct 19, 2026
- Market cap
- $7.45B
- P/E (TTM)
- 113.1
- Dividend yield
- –
Alkermes plc. balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 84.6%
- Operating margin
- 7.0%
- Net margin
- 4.0%
- Return on equity, FY2025
- 14.7%
Financial strength
- Current ratio
- 2.30
- Debt to equity
- 0.83
- Debt to assets
- 34.2%
- Cash to current liabilities
- 77.3%
Valuation
- P/E ratio
- 113.1
- Price to sales
- 4.47
- Price to book
- 4.12
- Dividend yield
- –